System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Matteo Monami is an expert in Endocrinology at Azienda Ospedaliero-Universitaria Careggi (Italy). As of November 2026, ScienceLeadR ranks Matteo Monami in the top 1% of experts worldwide for Foot Diseases, Skin Ulcer and Diabetes Complications. Matteo Monami has authored 310 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 2 of them ongoing. SLR score: 1,147 (community average: 125). How the SLR is computed.

LeadR Profile

Matteo Monami Azienda Ospedaliero-Universitaria Careggi Italy
1 147 ScienceLeadR Reputation 1147

Unlock

Register Login
Network Map

Endocrinology

Subspecialties: Nutrition - Surgery - Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2005 - 2026
Source: PubMed

University of Florence

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 310

Citations

Citations: 13 004 1st author: 97 Last author: 39 Unique author: 11

Main journals

Acta Diabetol 41
Diabetes Obes Metab 40
Nutr Metab Cardiovasc Dis 30
J Sex Med 19
Diabetes Res Clin Pract 18

Best Journals

Nat Med 4
N Engl J Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Exploring esophageal vasculopathy in systemic sclerosis through left gastric artery Doppler ultrasound: a pilot study.
PMID 42957936 — pilot projects, sclerosis, ultrasonography, doppler, pilots, arteries, ultrasonics, gastric artery, scleroderma, systemic		Clin Rheumatol20260
Metabolic Bariatric Surgery for Cancer Prevention and Risk Reduction in Patients with Obesity: A GRADE-Based International Federation for the Surgery and Other Therapies for Obesity (IFSO) Position Statement.
PMID 42834256 — incidence, neoplasms, bariatric surgery, obesity, weight loss, therapeutics		Obes Surg20260
Nutritional Status at Admission and Clinical Outcomes in Hospitalized Patients with COVID-19: Results from the MODIeCOSe in Italy Study.
PMID 42942949 — malnutrition, food, covid-19, anthropometry, nutritional status, intensive care units, prognosis, acute disease		Nutrients20260
Incretin-Based Therapy in Patients with Malignancy and Obesity or Type 2 Diabetes. An Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF), and Italian Society of Obesity (SIO) Position Paper.
PMID 42823599 — diabetes mellitus, endocrinology, neoplasms, pharmacology, obesity, incretins, therapeutics, medical oncology, drug interactions, diabetes mellitus, type 2		Obes Rev20260
Urban Burden Index-Multidomain Assessment of Integrated Obesogenic Risk (UBI-MAIOR) and Obesity Prevalence Across 10 Metropolitan Areas: An Exploratory Pilot Analysis.
PMID 42712120 — built environment, pilots, prevalence, environment design, obesity		Diabetes Obes Metab20260

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 4
Phase 2 2

By status:

Completed 3
Not yet recruiting 1
Recruiting 1
Unknown 1

By type:

Interventional 6

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 2
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Efficacy and Safety of Stimulan for the Treatment of Diabetic Foot Osteomyelitis The BIG D FOOT Study
NCT06262854 — diabetes mellitus, osteomyelitis, safety, surgical procedures, operative, foot, foot ulcer, ulcer, diabetic foot, calcium, therapeutics		N/ANot yet recruiting2024
PHOTOFINISH a Clinical Study To Evaluate The Efficacy And Safety Of the System VULNOFAST Plus VULNOLIGHT In Addition To The Usual Care (UC) Vs UC Alone For The Treatment Of Infected Diabetic Foot Ulcers
NCT05613985 — photochemotherapy, safety, foot, foot ulcer, anti-infective agents, local, ulcer, diabetic foot, solutions, paraffin, therapeutics, tissues, debridement, infections		N/ARecruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS